Cargando…
New insights into the activities and toxicities of the old anticancer drug doxorubicin
The anthracycline drug doxorubicin is among the most used—and useful—chemotherapeutics. While doxorubicin is highly effective in the treatment of various hematopoietic malignancies and solid tumours, its application is limited by severe adverse effects, including irreversible cardiotoxicity, therapy...
Autores principales: | van der Zanden, Sabina Y., Qiao, Xiaohang, Neefjes, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597086/ https://www.ncbi.nlm.nih.gov/pubmed/33022843 http://dx.doi.org/10.1111/febs.15583 |
Ejemplares similares
-
Doxorubicin and Aclarubicin: Shuffling Anthracycline
Glycans for Improved Anticancer Agents
por: Wander, Dennis P. A., et al.
Publicado: (2020) -
Inherited Thoracic Aortic Disease: New Insights and Translational Targets
por: Fletcher, Alexander J., et al.
Publicado: (2020) -
Synthetic (N,N-Dimethyl)doxorubicin
Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline
Anticancer Drugs
por: Wander, Dennis P. A., et al.
Publicado: (2021) -
Toxicity of Chimeric Antigen Receptor T Cells and its Management
por: Wudhikarn, Kitsada, et al.
Publicado: (2021) -
Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
por: Luu, Albert Z., et al.
Publicado: (2018)